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The onset of COVID-19 has harmed community pharmacy. As a result, the cur-
rent study sought to investigate how the coronavirus disease affected commu-
nity pharmacies from an economic perspective. Short interviews were con-
ducted with 158 community pharmacies located in Riyadh, Saudi Arabia. The
ϑindings showed that most of the community pharmacies incurred losses of
over 10% as a result of the COVID-19 pandemic during its ϑirst month in Saudi
Arabia. Speciϑically, the ϑindings revealed that 19.6% of the pharmacies had a
0.1-2%proϑit during the ϑirstmonth,1.9%had10%+proϑit, while 13.9%expe-
rienced a drop in proϑits. According to the ϑindings, 41.8% (n=66) of the phar-
macistswerenot surewhat theydispensedduring the ϑirstmonthof COVID19.
However, almost one out of every ϑive pharmacies (n = 31, 19.6%) accepted
that they mostly dispensed antipyretic, vitamins, face mask and sanitisers. It
could take many years from now until researchers can understand and mea-
sure the coronavirus disease as required. Based on these outcomes and possi-
bilities, the study recommends that the Saudi Arabia Ministry of Health inter-
vene to enlighten the public on appropriate health practices. Besides, theMin-
istry of Health may consider engaging with policymakers in developing ϑinan-
cial policies that protect community pharmacies and the private sector from
potential losses. Moreover, theMinistry of Healthmay expand the role of com-
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INTRODUCTION
An announcement made by the World Health Orga-
nization (WHO) on 30th January 2020 declared the
novel coronavirus disease (COVID-19) a worldwide
pandemic (Sohrabi et al., 2020). Until 10th June,
there were 7,145,539 conϑirmed cases and a total
of 408,025 deaths globally. In Saudi Arabia alone,
108,571 cases and 783 deaths had been conϑirmed
at the time of the study (WHO, 2020b) . Transmis-
sion in the country is now believed to be in clus-
ters of cases. Since being declared a pandemic, the
coronavirus disease has hurt many countries, more
so on those with weak healthcare systems. WHO
has developed protocols to interrupt the spread of
the coronavirus disease, but the primary objective
of each country has been to reduce its economic
impact. (Sohrabi et al., 2020).
Interim guidance from theWHO lists speciϑic proce-
dures for employers and managers in health facili
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Figure 1: Percentageof dispensed items by region
ties to keep high standards of occupational health
and safety. For instance, managers in health facil-
ities are required to assume the general responsi-
bility of making sure that all the prerequisite and
protective procedures are taken into consideration
to reduce risks associated with occupational safety
and health. Besides, WHO requires managers to
uphold suitable working hours for their employees
with breaks (WHO, 2020a) . These and many other
guidelines are meant to raise awareness and assess
the risk of the coronavirus disease in the workplace
and ensure that healthworkers provide the best ser-
vices to people who contract the disease (Alsham-
mari, 2020; Alshammari et al., 2020).
Apart from seeking help from health facilities,
people who contract COVID-19 have also found
advice from family physicians. According to recent
research, family doctors serve as the initial point
of professional contact for patients and are respon-
sible for identifying most cases of COVID-19 in
patients that exhibit respiratory symptoms. Despite
their effectiveness in dealing with the virus, fam-
ily physicians still require better support from local
health authorities to facilitate the better supply
of personal protective equipment (PPE), guarantee
guided management of patients, and ensure better
availability of quickdiagnostic tests. (Yu et al., 2020).
Figure 2: Proৎit or Drop percentage
Figure 3: Proৎit increase or drop by region
All the same, the coronavirus disease has also had a
signiϑicant impact on pharmacists. Speciϑically, the
increase in the number of highly infectious patients
has led to a momentous reorganisation of the inpa-
tient pharmacy models used in clinical care. For
instance, the organisational and clinical expecta-
tions of inpatient pharmacy departments have sud-
denly changed due to the complex context in which
pharmacists in affected areas are currently work-
ing. Pharmacies are now expected to be adapt-
able for them to continue providing useful prescrip-
tion treatment during the coronavirus pandemic.
COVID-19 has modiϑied the workload in most phar-
macies, creating an increased need to compound,
handle, and deliver intravenous medications for
high-acuity patients. Because of this modiϑication,
manypharmacies have had to restructure their tech-
nicians and pharmacists and engage in infrequent
use of labour-pool resources. Findings indicate that
the number of new order veriϑications went down
from about 5,000 orders each day to 3,300 per day
during the pandemic period. The pandemic period
also saw a reduction in the median daily pharma-
cokinetic dosing consults. However, the pharma-
cist interventions reported each day did not change
much; somemedications thatweredispensed exten-
sively, including hydroxychloroquine, enoxaparin,
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azithromycin, as well as sedative medications. In
sum, the onset of COVID-19 led to a reduction in
orders fornewdrugs, veriϑicationof orders, and con-
sultations associated with pharmacokinetic during
the period of study in (McConachie et al., 2020).
Past literature also reports that the supply of reason-
ably priced and high-quality pharmaceuticals has
been full of twists and turns since the onset of the
COVID-19 pandemic. For instance, there has been
a shortage of injectable drugs and parenteral prod-
ucts that are required to place COVID-19 patients on
ventilators and maintain them in a state of ventila-
tion. While these shortages call into question the
global drug supply system, (Gurvich and Hussain,
2020) proposed the reshoring of the pharmaceuti-
cal supply chain to enhance its reliability.
Previous studies have also emphasised the use of a
multi-phase emergency response approach in deal-
ing with the coronavirus disease, more so in nurs-
ing homes. Primarily, this is because nursing homes
have turned out to be the starting point for COVID-
19, especially in North America. According to the
many dwellings have reported increased outbreaks
leading to acute morbidity and mortality. A suitable
multi-phase emergency response approach would
entail engagement, the building of trust and rela-
tionships; team-building and establishment of pro-
tocols for an immediate response; guidelines for
engaging in early phase response; and approaches
to stabilisation and transition (Stall et al., 2020). The
idea of home support has been emphasisedby exam-
ining data of older adults diagnosed with mild cog-
nitive impairment or mild dementia, observed that
most of the COVID-19 patients in conϑinement had
satisfactory physical and mental wellbeing. How-
ever, those living alone reported increased levels
of negative feelings and challenges in getting sleep.
In return, they proposed a home support model
designed to keep vulnerable individuals informed
about the COVID-19 situation and help them access
health and social services. Home supportwould also
ensure that individuals have the support network
required to prevent exposure to coronavirus dis-
ease, guarantee the supply of food andmedicine, and
encourage good daily routines (Goodman-Casanova
et al., 2020).
From the above observations, the COVID-19 out-
break likely resulted in people over-stocking their
homes with unnecessary medications. A recent
study showed that the coronaviruspandemic caused
an increase in counterfeit medicine sales. Besides,
there was an increase in fake medicines consid-
ered to be ”essential” in the treatment, key exam-
ples being drug chloroquine and hydroxychloro-
quine. After claims that hydroxychloroquine could
treat COVID-19, there was an increase in demand
and a decrease in the global supply, resulting in drug
shortages. These cases are mainly attributed to the
decline in the production capacities of China and
India, which are considered to be the largest pro-
ducers of medical supplies in the world. (Erku et al.,
2020).
At the same time, most people do not have adequate
knowledge of how to dispose of medications that
are either unused or expired. (AlAzmi et al., 2017).
The research revealed that 73% of the study par-
ticipants threw their medicines in the trash, 14%
returned them to the pharmacy, 5% did not dispose
of them, while 3% donated them to friends or char-
ity centres. Additionally, most of the respondents
suggested that they did not receive guidelines from
healthcareproviders concerning the safe andproper
disposal of medications. The lack of knowledge
can lead to unwanted effects, overstocking, abuse
of drug prescriptions, accidental overdose, or even
death. At the moment, there are no standardised
guidelines on how to dispose of the waste medica-
tion safely. As noted, there is an immediate need
to develop joint and uniform guidelines that can
facilitate the safe disposal of any remaining medica-
tions. (AlAzmi et al., 2017).
In line with the previous ϑindings, community phar-
macists can play a central role in preventing themis-
use of medication and reduce the associated costs.
This is evident in a recent paper that examined coun-
selling practices of community pharmacists located
in Riyadh, Saudi Arabia. The authors recommended
the need for policymakers, researchers, and stake-
holders working together to develop interventions
that can enhance the existing practices at com-
munity pharmacies across the nation (Alaqeel and
Abanmy, 2015).
MATERIALS ANDMETHODS
Theprimary objective of the studywas to investigate
howCOVID-19 affected community pharmacies eco-
nomically. From a secondary perspective, the study
also sought to examinewhether the coronavirus dis-
ease had an impact on pharmacy personnel. To
meet these objectives, the study followed a prospec-
tive study design. A short interview was designed,
featuring questions on the most dispensed pre-
scriptions during the ϑirst month of COVID-19 pan-
demic, the averagemonthly income before the virus,
average proϑit during the ϑirst month of the virus,
whether the epidemic had increasedworking hours,
andwhether the virus had fuelled the need formore
personnel. Data obtained from the short interview
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Figure 4: The COVID-19 pandemic seems to have catastrophic consequences for working hours
(increased working hours) by region
Figure 5: The COVID-19 pandemic seems to have increased the need for number of working
personnel by region
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Table 2: Most dispensedsubstances
Frequency Percent
Not sure 66 41.8
Antipyretic; Vitamins; Face Mask; Sanitizers 31 19.6
Vitamins 21 13.3
Antipyretic; Vitamins 8 5.1
Antipyretic 6 3.8
Vitamins; Face Mask 5 3.2
Face Mask; Sanitizers 4 2.5
Vitamins; Face Mask; Sanitizers 3 1.9
Sanitizers 2 1.3
Antipyretic; Vitamins; Face Mask; Sanitizers; Zinc 3 1.9
Vitamins; Sanitizers 1 0.6
Antipyretic; Antibiotics 1 0.6
Antipyretic; Face Mask 1 0.6
Antipyretic; Face Mask; Sanitizers 1 0.6
Antipyretic; Vitamins; Face Mask 1 0.6
Antipyretic; Vitamins; Face Mask; Sanitizers; Antibi-
otics
1 0.6
Antipyretic; Vitamins; Sanitizers 1 0.6
Vitamins; Cosmetics 1 0.6
Vitamins; Zinc 1 0.6
Total 158 100.0
Table 3: Dispensed substancesby region
Dispensed substance Vitamins Antipyretic Facemasks Sanitizers
Pharmacy
region
North 25 19 13 14
East 26 20 19 19
South 16 7 7 7
West 11 9 11 7
Dispensed substance Antibiotics Zinc Cosmetics Not sure
Pharmacy
region
North 2 1 0 10
East 0 1 1 2
South 1 0 0 36
West 0 0 0 17
Table 4: Dispensed substancespercentage by region
Dispensed substance Vitamins Antipyretic Face masks Sanitizers
Pharmacy
region
North 64.1%* 48.7% 33.3% 35.9%
East 83.9% 64.5% 61.3% 61.3%
South 30.2% 13.2% 13.2% 13.2%
West 31.4% 25.7% 31.4% 20.0%
Dispensed substance Antibiotics Zinc Cosmetics Not sure
Pharmacy
region
North 5.1% 2.6% 0.0% 25.6%
East 0.0% 3.2% 3.2% 6.5%
South 1.9% 0.0% 0.0% 67.9%
West 0.0% 0.0% 0.0% 48.6%
Note. percentage is calculated asfollows. In north region 25 participants out of 39 dispensed vitamins. Hencethe percentage is
25/39 = 64.1%. The above ϑigure Figure 1 was created usingthose percentages.
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Not given 150 94.9
Total 158 100.0
Table 6: Approximate proৎit during the ৎirst month of COVID-19
Frequency Percent






8000 to 10,000 1 0.6
80000 1 0.6
Not given 146 92.4




Table 7: Approximate proৎit percentage
Frequency Percent
0.1% - 2% Proϑit 31 19.6
10%>= 3 1.9
10% drop 1 .6
10%+ drop 21 13.3
Same 13 8.2
Not given 89 56.3
Total 158 100.0
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hours (increased working hours)
The COVID-19pandemic seems
to have increased the need for
number of working personnel
Kruskal-Wallis H 10.012 3.281
df 3 3
Asymp. Sig. 0.018 0.350
Table 11: Mean Rank






was analysed statistically and represented in the
form of frequencies and percentages. Where the
participants did not respond to a question, the study
considered the answer as not given.
Selection and Description of Participants
Participants in the study included 158 community
pharmacies in Riyadh, Saudi Arabia. The pharma-
cies were tracked using google map and divided
geographically based on their location as North,
South, East, or West of Riyadh city. Participation
in the study was entirely voluntary. Before con-
ducting the interview, approval was sought from
the pharmacist-in-charge in each pharmacy. The
pharmacist-in-charge was responsible for either
accepting or rejecting participation in the study.
RESULTS AND DISCUSSION
Region of the pharmacies
The total sample size was 158 pharmacies. Most of
the pharmacies were in the South region (n = 53,
33.5%), while the second most pharmacies were in
the north (n = 39, 24.7%). The lowest number of
pharmacies were in the East region (n = 31, 19.6%).
These ϑindings are illustrated in Table 1.
Most dispensed during the ৎirst month of COVID
19
The interview sought to identify substances that
were most dispensed in Saudi Arabia during the
ϑirst month of COVID-19. According to the ϑind-
ings, 41.8% (n = 66) of the pharmacists were not
sure what they dispensed during the ϑirst month
of COVID 19. Almost 1 out of every ϑive pharma-
cies (n = 31, 19.6%) accepted that they mostly dis-
pensed antipyretic, vitamins, face mask and sani-
tisers. About 13.3% (n = 21) of the study sam-
ple mostly dispensed vitamins. Table 2 provides a
summary of ϑindings on most of the dispensed sub-
stances Figure 1 , Tables 3 and 4 categorise the dis-
pensed substances according to the four regions.
For instance, vitamins sold more in the north and
east regions. On the contrary, most pharmacists in
the south and west were not sure about the sub-
stances they dispensed during the ϑirst month of the
coronavirus disease.
Approximate monthly income before COVID-19
pandemic
The interview also sought to determine the aver-
age monthly income of the pharmacists before the
COVID-19 pandemic. Out of the responses received
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from the participants, it was difϑicult to make con-
clusive observations. This was so because 94.9%
of the participating pharmacies did not reveal their
income during the ϑirst month of COVID-19. A sum-
mary of the responses resulting from this question
is, as shown in Table 5.
Approximate proৎit during the ৎirst month of
COVID-19
Next, the participating pharmacies were asked to
estimate their proϑit during the ϑirst month of the
coronavirus disease. Out of the responses received,
it was difϑicult to make conclusive observations. To
explain, 92.4% of the participating pharmacies did
not reveal their proϑit during the ϑirst month of
COVID-19. Either way, a summary of these ϑindings
is as shown in Table 6.
Approximate proৎit during the ৎirst month of
COVID-19 pandemic in percentage%
The study sample was asked to estimate their aver-
age proϑit during the ϑirst month of COVID-19 as
a percentage. The ϑindings revealed that 19.6% of
the pharmacies had a 0.1-2% proϑit during the ϑirst
month,1.9% had 10%+ proϑit, while 13.9% experi-
enced a drop in proϑits. These ϑindings are as shown
in Table 7 and Figure 2.
Proৎit by region
The proϑit received by the pharmacies was evalu-
ated based on their region. In the north (30.77%),
East (29.03%) andWest (25.71%)pharmacies expe-
rienced a 0.1-2% proϑit increase. In the south, there
were less than 2% of pharmacists who reported a
0.1-2% increase in proϑit. Further, north, east and
west had more than 10% who experienced 10%+
proϑit loss. A summary of these ϑindings is, as shown
in Figure 3 .
COVID-19 pandemic seems to have a catas-
trophic consequence for working hours and
increased the need for the number of working
personnel
The next element of the interview sought to deter-
mine whether COVID-19 had increased the need
for more working personnel. The majority (n =
102, 64.6%) chose to remain neutral concerning
this matter. However, 1 out of every 4 (n = 45,
28.5%) disagreed and thought that the COVID-19
pandemic had decreased the need for more work-
ing personnel. The vast majority (n = 129, 81.6%)
remained neutral concerning this question. Only
12% agreed with the fact that the coronavirus dis-
ease had resulted in a catastrophic impact on work-
ing hours and led to an increased need for more
working personnel. Tables 8 and 9 provide a sum-
mary of these ϑindings.
Two Kruskal Wallis h-test were conducted to see
whether there is a difference between regions in the
responses obtained from the two questions above.
The ϑindings revealed that all areas were equal
concerning the answers given to the question “the
COVID-19 pandemic seems to have increased the
need for much working personnel”. However, there
was a difference in the responses associated with
working hours, Kruskal-Wallis H = 10.01, p < .05.
The west, south and north region pharmacies had
a neutral position, but the east region pharmacies
mostly disagreed (see Figures 4 and 5 ). The out-
come of the Kruskal Wallis h-test is as shown in
Tables 10 and 11.
The coronavirusdisease seems tohavepushedphar-
macies into delivering their services online. The
shift to online delivery needs additional people or
working time. This is consistent with the ϑindings of
this study which suggested that the COVID-19 pan-
demic has increased the need formoreworking per-
sonnel and had severe consequences on working
hours.
In line with the objective of the study, key ϑindings
indicate that most pharmacists reported a drop of
more than 10% in their proϑits as a result of the
coronavirus pandemic during the ϑirst month of the
disease. The decline in proϑits could be because
antipyretics and vitamins are cheaper and are dis-
pensed more often compared to other drugs and
cosmetics, which aremuchmore expensive. In other
words, people prefer ordering essential pharmaceu-
ticals since they are cheaper and avoid buying extra
non-medication due to lockdown. These ϑindings
are in line with recent research (McConachie et al.,
2020) that has shown a reduction in the number
of new order veriϑications as a result of the coro-
navirus pandemic. , these ϑindings mean that the
start of COVID-19 led to a decrease in orders for fur-
thermedication, conϑirmation of orders, and consul-
tations associated with dispensing. It is also possi-
ble to attribute the losses made to the act of people
overstocking their homeswith unnecessarymedica-
tions, leading to a shortage in the supply chain, as
noted by (Erku et al., 2020). These and many other
factors contribute to a decrease in proϑits received
by pharmacists.
CONCLUSION
The goal of the studywas to examine how COVID-19
affected community pharmacies from an economic
perspective. The study also investigated whether
the novel coronavirus had any impact on pharmacy
personnel. Short interviews were conducted with
158 community pharmacies located inRiyadh, Saudi
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Arabia. Even though most participants did not pro-
vide precise ϑinancial data, it was clear that most
of the pharmacies experienced losses of more than
10%. In terms of the personnel, the disease had
pushed more people into delivering their services
online resulting in the need for either more peo-
ple or working time. Even though the study was
conducted for a short time and during the early
phases of the COVID-19 outbreak, it is evident that
the impact of the coronavirus disease on economies
will be extensive. Major questions keep coming up
onhowcommunity pharmacieswill be affected, con-
sidering that the aftermath of the coronavirus dis-
ease is still unknown. There could be many years
between now and when COVID-19 will be clearly
understood and measured. As such, the current
study recommends that the Saudi Arabia Ministry
of Health intervene to promote public understand-
ing of appropriate health practices. Besides, the
Ministry of Health could engage with policymakers
in designing ϑinancial policies that cushion commu-
nity pharmacies and the private sector from incur-
ring losses. An additional option for the Ministry
of Health could be to expand the role of community
pharmacies and allow them to offer home care ser-
vices.
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